mimoleculeindex.com
indexsame ingredientsame route
inspect molecule / tice bcg

Tice Bcg

Bacillus Calmette-Guerin Substrain Tice Live Antigen
  o--o
   \/
   /\
  o--o

Bacillus Calmette-Guerin Substrain Tice Live Antigen is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.

active moietyBacillus Calmette-Guerin Substrain Tice Live Antigen
administration routeIntravesical
price comparison status2 snapshots
safety signal rating54 / 100
Actively Acquired Immunity [PE]openFDA NDC seedopenFDA NDC50 mg/50mL
price index

Typical Class Estimates

⚠ Verified price snapshots are queued for this brand/package. Showing typical market estimates based on the drug class: Actively Acquired Immunity [PE].
$24.50USvsCA$14.20CA

Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.

query trend --id 3552 --12m

Price Trend Index

Deterministic trailing 12-month value delta index for this active ingredient class.

Rising Fast3M: +1.7%12M: +6.4%
Jul 2025
▂▃▃▄▄▅▅▆▇▇█
Jun 2026
Jan 2026$23.86
Feb 2026$23.89
Mar 2026$24.08
Apr 2026$24.28
May 2026$24.30
Jun 2026$24.50
01 / chemistryMerck Sharp & Dohme LLC

Ingredient Breakdown

active moietyBacillus Calmette-Guerin Substrain Tice Live Antigen
formulationIntravesical Actively Acquired Immunity [PE]
mechanism of action

Actively Acquired Immunity [PE]

available strengths
50 mg/50mL

label source: registry ↗

02 / ingredientsexcipients

Excipients / Maker Notes

  • Not enriched yet from label source.

Manufacturer Notes

  • This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals

Steps To Take Safely

  1. Use the ingredient name as the anchor before comparing any brand or pharmacy listing.
  2. Read the official label for route-specific directions, contraindications, and storage.
  3. Ask a clinician or pharmacist before substituting products across countries or formulations.
  4. Treat severe or rapidly worsening symptoms as urgent, especially after starting or changing a medicine.

Side-Effect Signals

  • label-specific reactions
  • allergic reaction
  • interaction risk
  • dose/formulation confusion
  • urgent symptoms require clinician review
Summary of index signals. Not active medical advice. Consult official labels and clinicians.

$ grep ingredient --same

Same Ingredient Sibling Records

All matches

No same-ingredient sibling appears in the current indexed records yet.